Author | Heather S. Han, MD | OncLive

Author | Heather S. Han, MD

Articles

Dr. Han on the Differences Between CDK 4/6 Inhibitors in ER+ Breast Cancer

March 30, 2018

Video

Heather S. Han, MD, research director, medical oncologist, Department of Breast Oncology, Moffitt Cancer Center, discusses the differences between CDK 4/6 inhibitors, and their efficacy as both single- and combination agents.

x